ALK-Abello A/S
CSE:ALK B

Watchlist Manager
ALK-Abello A/S Logo
ALK-Abello A/S
CSE:ALK B
Watchlist
Price: 152 DKK -2.5% Market Closed
Updated: May 18, 2024
Section:
 

Relative Value

The Relative Value of one ALK B stock under the Base Case scenario is hidden DKK. Compared to the current market price of 152 DKK, ALK-Abello A/S is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ALK B Relative Value
HIDDEN
Unlock
Worst Case
Base Case
Best Case

Valuation Multiples

6.8
P/S
P/S
Price to Sales
6.8
vs History
30
vs Industry
21
Median 3Y
6.1
Median 5Y
5
Industry
2.5
Forward
6.1
More Details
60.6
P/E
P/E
Price to Earnings
60.6
vs History
44
vs Industry
7
Median 3Y
77.2
Median 5Y
54.2
Industry
23.5
Forward
45.1
More Details
42.3
P/OCF
P/OCF
Price to OCF
42.3
vs History
50
vs Industry
9
Median 3Y
54.6
Median 5Y
46.5
Industry
17.4
More Details
141.4
P/FCFE
P/FCFE
Price to FCFE
141.4
vs History
23
vs Industry
5
Median 3Y
-168.2
Median 5Y
-15.3
Industry
24.3
More Details
7.2
P/B
P/B
Price to Book Value
7.2
vs History
33
vs Industry
9
Median 3Y
6.8
Median 5Y
5.5
Industry
2.1
More Details
6.8
EV/S
EV/S
Enterprise Value to Sales
6.8
vs History
31
vs Industry
19
Median 3Y
6.2
Median 5Y
5.1
Industry
2.6
Forward
6.1
More Details
10.8
EV/GP
EV/GP
Enterprise Value to Gross Profit
10.8
vs History
31
vs Industry
19
Median 3Y
9.9
Median 5Y
8.1
Industry
5.3
More Details
33.6
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
33.6
vs History
38
vs Industry
10
Median 3Y
40.3
Median 5Y
27.5
Industry
13.7
Forward
26.1
More Details
44.8
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
44.8
vs History
47
vs Industry
9
Median 3Y
63.1
Median 5Y
45.6
Industry
17.4
Forward
32.2
More Details
42.5
EV/OCF
EV/OCF
Enterprise Value to OCF
42.5
vs History
50
vs Industry
10
Median 3Y
55.1
Median 5Y
47
Industry
16.2
More Details
75.3
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
75.3
vs History
57
vs Industry
7
Median 3Y
183.4
Median 5Y
113.7
Industry
18.6
More Details
5.3
EV/IC
EV/IC
Enterprise Value to IC
5.3
vs History
20
vs Industry
16
Median 3Y
4.7
Median 5Y
3.8
Industry
1.9
More Details

Multiples Across Competitors

ALK B Competitors Multiples
ALK-Abello A/S Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
DK
ALK-Abello A/S
CSE:ALK B
33.6B DKK 6.8 60.6 33.6 44.8
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
731.8B USD 20.4 119.2 58.4 66.4
DK
Novo Nordisk A/S
CSE:NOVO B
4T DKK 16.5 45.1 33.6 36.9
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
372.2B USD 4.3 9.7 11.9 15.6
US
Merck & Co Inc
NYSE:MRK
332.3B USD 5.4 144.1 35.9 58.5
UK
AstraZeneca PLC
LSE:AZN
187.7B GBP 5 37.6 174.5 278.3
CH
Roche Holding AG
SIX:ROG
189B CHF 3.2 16.4 9.3 11
CH
Novartis AG
SIX:NOVN
182.7B CHF 3.4 11.5 8.7 12.7
US
Pfizer Inc
NYSE:PFE
161.7B USD 2.9 -523.3 12.9 20.6
P/E Multiple
Earnings Growth
DK
ALK-Abello A/S
CSE:ALK B
Average P/E: 55.5
60.6
148%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
119.2
346%
DK
Novo Nordisk A/S
CSE:NOVO B
45.1
84%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
US
Johnson & Johnson
NYSE:JNJ
9.7
-21%
US
Merck & Co Inc
NYSE:MRK
144.1
7 453%
UK
AstraZeneca PLC
LSE:AZN
37.6
168%
CH
Roche Holding AG
SIX:ROG
16.4
26%
CH
Novartis AG
SIX:NOVN
11.5
15%
US
Pfizer Inc
NYSE:PFE
Negative Multiple: -523.3
680%

See Also

Summary
ALK B intrinsic value, competitors valuation, and company profile.
DCF Valuation
ALK B stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ALK B stock valuation using valuation multiples.
Wall Street Estimates
ALK B price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ALK B stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 138,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.